Krishnamurthy; Thinnayam N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Krishnamurthy; Thinnayam N..The latest application filed is for "methods of treating attention deficit hyperactivity disorder".

Company Profile

1.16.11

Krishnamurthy; Thinnayam N. - Scarborough CA
Krishnamurthy; Thinnayam N. - Ontario CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Controlled release formulations Grant 10,463,624 - Krishnamurthy , et al. No	2019-11-05
Methods of treating attention deficit hyperactivity disorder Grant 10,039,719 - Krishnamurthy , et al. August 7, 2	2018-08-07
Methods of preparing oral controlled release formulations Grant 10,022,330 - Krishnamurthy , et al. July 17, 2	2018-07-17
Methods of treating attention deficit hyperactivity disorder Grant 9,949,931 - Krishnamurthy , et al. April 24, 2	2018-04-24
Methods of treating attention deficit hyperactivity disorder App 20180042854 - Krishnamurthy; Thinnayam N. ; et al.	2018-02-15
Controlled Release Formulations App 20180008544 - Krishnamurthy; Thinnayam N. ; et al.	2018-01-11
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations Grant 9,801,823 - Krishnamurthy , et al. October 31, 2	2017-10-31
Controlled Release Formulations Having Rapid Onset And Rapid Decline Of Effective Plasma Drug Concentrations App 20170135999 - Krishnamurthy; Thinnayam N. ; et al.	2017-05-18
Methods Of Preparing Oral Controlled Release Formulations App 20170079921 - Krishnamurthy; Thinnayam N. ; et al.	2017-03-23
Methods Of Treating Attention Deficit Hyperactivity Disorder App 20170071926 - Krishnamurthy; Thinnayam N. ; et al.	2017-03-16
Controlled Release Formulations Having Rapid Onset And Rapid Decline Of Effective Plasma Drug Concentrations App 20150313850 - Krishnamurthy; Thinnayam N. ; et al.	2015-11-05
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations Grant 9,066,869 - Krishnamurthy , et al. June 30, 2	2015-06-30
Controlled Release Formulations Having Rapid Onset And Rapid Decline Of Effective Plasma Drug Concentrations App 20140099361 - Krishnamurthy; Thinnayam N. ; et al.	2014-04-10
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations Grant 8,580,310 - Krishnamurthy , et al. November 12, 2	2013-11-12
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations App 20090123554 - Krishnamurthy; Thinnayam N. ; et al.	2009-05-14
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations Grant 7,438,930 - Krishnamurthy , et al. October 21, 2	2008-10-21
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations App 20070264325 - Krishnamurthy; Thinnayam N. ; et al.	2007-11-15
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations Grant 7,247,318 - Krishnamurthy , et al. July 24, 2	2007-07-24
Controlled/modified release oral methylphenidate formulations Grant 7,083,808 - Goldenheim , et al. August 1, 2	2006-08-01
Controlled/modified release oral methylphenidate formulations App 20040131680 - Goldenheim, Paul D. ; et al.	2004-07-08
Controlled/modified release oral methylphenidate formulations Grant 6,673,367 - Goldenheim , et al. January 6, 2	2004-01-06
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations App 20030054033 - Krishnamurthy, Thinnayam N. ; et al.	2003-03-20
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations Grant 6,419,960 - Krishnamurthy , et al. July 16, 2	2002-07-16
Controlled release matrix for pharmaceuticals Grant 5,811,126 - Krishnamurthy September 22, 1	1998-09-22
Controlled release matrix for pharmaceuticals Grant 5,508,043 - Krishnamurthy April 16, 1	1996-04-16
Controlled release matrix suppository for pharmaceuticals Grant 5,215,758 - Krishnamurthy June 1, 1	1993-06-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.